Amplio Pharma closes first qualified investment round with Amsterdam UMC Ventures Holding / LEH consortium
Parkinnova therapeutics receives funding from INH
Phlox Therapeutics Secures New Funding to Advance RNA Therapies for Genetic Cardiomyopathies
Kepler Vision Technologies receives investment of €1.5 million
UvA Ventures Holding has launched the Social Sciences & Humanities (SSH) Impact Fund
Ellogon secures a €1 million investment for immunotherapy innovation
